Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An evaluation of enasidenib for the treatment of acute myeloid leukemia.
Del Principe MI, Paterno G, Palmieri R, Maurillo L, Buccisano F, Venditti A. Del Principe MI, et al. Among authors: palmieri r. Expert Opin Pharmacother. 2019 Nov;20(16):1935-1942. doi: 10.1080/14656566.2019.1654456. Epub 2019 Aug 27. Expert Opin Pharmacother. 2019. PMID: 31454277 Review.
Diagnostic Performance and Safety of Bronchoalveolar Lavage in Thrombocytopenic Haematological Patients for Invasive Fungal Infections Diagnosis: A Monocentric, Retrospective Experience.
Cefalo M, Puxeddu E, Sarmati L, Paterno G, Fontana C, Nasso D, Pane G, De Bellis E, Palmieri R, Buzzati E, Meconi F, Laureana R, Casciani P, Zizzari AG, Rogliani P, de Fabritiis P, Maurillo L, Buccisano F, Cantonetti M, Arcese W, Venditti A, Del Principe MI. Cefalo M, et al. Among authors: palmieri r. Mediterr J Hematol Infect Dis. 2019 Nov 1;11(1):e2019065. doi: 10.4084/MJHID.2019.065. eCollection 2019. Mediterr J Hematol Infect Dis. 2019. PMID: 31700590 Free PMC article.
Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation.
Buccisano F, Palmieri R, Piciocchi A, Maurillo L, Del Principe MI, Paterno G, Soddu S, Cerretti R, De Angelis G, Mariotti B, Irno Consalvo MA, Conti C, Fraboni D, Divona M, Ottone T, Lavorgna S, Panetta P, Voso MT, Arcese W, Venditti A. Buccisano F, et al. Among authors: palmieri r. Cancers (Basel). 2021 Mar 3;13(5):1083. doi: 10.3390/cancers13051083. Cancers (Basel). 2021. PMID: 33802502 Free PMC article.
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.
Iannetta M, Buccisano F, Fraboni D, Malagnino V, Campogiani L, Teti E, Spalliera I, Rossi B, Di Lorenzo A, Palmieri R, Crea A, Zordan M, Vitale P, Voso MT, Andreoni M, Sarmati L. Iannetta M, et al. Among authors: palmieri r. Sci Rep. 2021 Jun 17;11(1):12762. doi: 10.1038/s41598-021-90983-0. Sci Rep. 2021. PMID: 34140530 Free PMC article.
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol.
Buccisano F, Palmieri R, Piciocchi A, Arena V, Candoni A, Melillo L, Calafiore V, Cairoli R, de Fabritiis P, Storti G, Salutari P, Lanza F, Martinelli G, Luppi M, Capria S, Maurillo L, Del Principe MI, Paterno G, Irno Consalvo MA, Ottone T, Lavorgna S, Voso MT, Fazi P, Vignetti M, Arcese W, Venditti A. Buccisano F, et al. Among authors: palmieri r. Blood Adv. 2022 Apr 26;6(8):2510-2516. doi: 10.1182/bloodadvances.2021005717. Blood Adv. 2022. PMID: 34731884 Free PMC article. Clinical Trial.
CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia.
Palmieri R, Buccisano F, Arena V, Irno Consalvo MA, Piciocchi A, Maurillo L, DelPrincipe MI, Di Veroli A, Paterno G, Conti C, Fraboni D, Voso MT, Arcese W, Venditti A. Palmieri R, et al. Leuk Lymphoma. 2022 Apr;63(4):996-1000. doi: 10.1080/10428194.2021.2005042. Epub 2021 Nov 21. Leuk Lymphoma. 2022. PMID: 34806525 No abstract available.
232 results